These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 29505490

  • 21. Successful clozapine rechallenge following prior intolerance to clozapine.
    Cohen SA.
    J Clin Psychiatry; 1994 Nov; 55(11):498-9. PubMed ID: 7989287
    [No Abstract] [Full Text] [Related]

  • 22. Clozapine Rechallenge Following Neuroleptic Malignant Syndrome: A Systematic Review.
    Lally J, McCaffrey C, OʼMurchu C, Krivoy A, Guerandel A, MacCabe JH, Gaughran F.
    J Clin Psychopharmacol; 2019 Nov; 39(4):372-379. PubMed ID: 31205196
    [Abstract] [Full Text] [Related]

  • 23. Clozapine-Associated Myocarditis: A Protocol for Monitoring Upon Clozapine Initiation and Recommendations for How to Conduct a Clozapine Rechallenge.
    Griffin JM, Woznica E, Gilotra NA, Nucifora FC.
    J Clin Psychopharmacol; 2019 Nov; 41(2):180-185. PubMed ID: 33587399
    [Abstract] [Full Text] [Related]

  • 24. Clozapine-induced cardiomyopathy and myocarditis monitoring: A systematic review.
    Knoph KN, Morgan RJ, Palmer BA, Schak KM, Owen AC, Leloux MR, Patel M, Leung JG.
    Schizophr Res; 2018 Sep; 199():17-30. PubMed ID: 29548760
    [Abstract] [Full Text] [Related]

  • 25. Clozapine-induced neuroleptic malignant syndrome: clozapine monotherapy rechallenge in a case of previous NMS.
    Illing M, Ancill R.
    Can J Psychiatry; 1996 May; 41(4):258. PubMed ID: 8726793
    [No Abstract] [Full Text] [Related]

  • 26. Add-on filgrastim during clozapine rechallenge in patients with a history of clozapine-related granulocytopenia/agranulocytosis.
    Joffe G, Eskelinen S, Sailas E.
    Am J Psychiatry; 2009 Feb; 166(2):236. PubMed ID: 19188296
    [No Abstract] [Full Text] [Related]

  • 27. Optimizing outcomes in clozapine rechallenge following neutropenia: a cohort analysis.
    Meyer N, Gee S, Whiskey E, Taylor D, Mijovic A, Gaughran F, Shergill S, MacCabe JH.
    J Clin Psychiatry; 2015 Nov; 76(11):e1410-6. PubMed ID: 26646037
    [Abstract] [Full Text] [Related]

  • 28. [Safety aspects during treatment with clozapine. : Monitoring and rechallenge - a narrative review].
    Berger SJ, Hofer A.
    Neuropsychiatr; 2023 Sep; 37(3):130-135. PubMed ID: 37389803
    [Abstract] [Full Text] [Related]

  • 29. Chart review for potential features of myocarditis, pericarditis, and cardiomyopathy in children and adolescents treated with clozapine.
    Wehmeier PM, Schüler-Springorum M, Heiser P, Remschmidt H.
    J Child Adolesc Psychopharmacol; 2004 Sep; 14(2):267-71. PubMed ID: 15319023
    [Abstract] [Full Text] [Related]

  • 30. Genetics of clozapine-associated neutropenia: recent advances, challenges and future perspective.
    Legge SE, Walters JT.
    Pharmacogenomics; 2019 Mar; 20(4):279-290. PubMed ID: 30767710
    [Abstract] [Full Text] [Related]

  • 31. Neutropenia and agranulocytosis during treatment of schizophrenia with clozapine versus other antipsychotics: an observational study in Iceland.
    Ingimarsson O, MacCabe JH, Haraldsson M, Jónsdóttir H, Sigurdsson E.
    BMC Psychiatry; 2016 Dec 12; 16(1):441. PubMed ID: 27955666
    [Abstract] [Full Text] [Related]

  • 32. Failure of rechallenge clozapine after agranulocytosis: A case report.
    Roméo B, Petillion A, Martelli C, Benyamina A.
    Encephale; 2019 Nov 12; 45(5):449-450. PubMed ID: 30878138
    [No Abstract] [Full Text] [Related]

  • 33. Clozapine-Related Myocarditis and Rechallenge: A Case Series and Clinical Review.
    Noël MC, Powell V, Burton L, Panda R, Remington G.
    J Clin Psychopharmacol; 2019 Nov 12; 39(4):380-385. PubMed ID: 31205188
    [Abstract] [Full Text] [Related]

  • 34. Neutropenia and Agranulocytosis in Chinese Patients Prescribed Clozapine.
    Lau KL, Yim PH.
    East Asian Arch Psychiatry; 2015 Dec 12; 25(4):164-7. PubMed ID: 26764291
    [Abstract] [Full Text] [Related]

  • 35. A case of agranulocytosis secondary to rechallenge with clozapine following severe neutropenia during previous therapy.
    Lertxundi U, Sanchez P, Hernandez R, Elizagarate E.
    J Clin Psychiatry; 2011 Dec 12; 72(12):1659. PubMed ID: 22244024
    [No Abstract] [Full Text] [Related]

  • 36. Rechallenge with clozapine following leucopenia or neutropenia during previous therapy.
    Dunk LR, Annan LJ, Andrews CD.
    Br J Psychiatry; 2006 Mar 12; 188():255-63. PubMed ID: 16507968
    [Abstract] [Full Text] [Related]

  • 37. Adverse cardiac effects associated with clozapine.
    Merrill DB, Dec GW, Goff DC.
    J Clin Psychopharmacol; 2005 Feb 12; 25(1):32-41. PubMed ID: 15643098
    [Abstract] [Full Text] [Related]

  • 38. Myocarditis, pericarditis and cardiomyopathy in patients treated with clozapine.
    Wehmeier PM, Heiser P, Remschmidt H.
    J Clin Pharm Ther; 2005 Feb 12; 30(1):91-6. PubMed ID: 15659009
    [Abstract] [Full Text] [Related]

  • 39. [Reaction on 'Myocarditis and cardiomyopathy underestimated complications resulting from clozapine therapy'].
    Schulte PF.
    Tijdschr Psychiatr; 2011 Feb 12; 53(3):193-4. PubMed ID: 21404176
    [No Abstract] [Full Text] [Related]

  • 40. [Reaction on 'Myocarditis and cardiomyopathy underestimated complications resulting from clozapine therapy'].
    Cohen D.
    Tijdschr Psychiatr; 2010 Feb 12; 52(10):727-8; author reply 728-9. PubMed ID: 20931487
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.